HilleVax, Inc. (HLVX)
NASDAQ: HLVX · Real-Time Price · USD
1.830
-0.040 (-2.14%)
Feb 21, 2025, 4:00 PM EST - Market closed
HilleVax Market Cap
HilleVax has a market cap or net worth of $88.27 million as of February 21, 2025. Its market cap has decreased by -87.43% in one year.
Market Cap
88.27M
Enterprise Value
-76.07M
1-Year Change
-87.43%
Ranking
Category
Stock Price
$1.83
Market Cap Chart
Since the IPO on April 29, 2022, HilleVax's market cap has decreased from $538.26M to $88.27M, a decrease of -83.60%. That is a compound annual growth rate of -47.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 88.27M | -11.59% |
| Dec 31, 2024 | 99.85M | -86.63% |
| Dec 29, 2023 | 746.58M | 25.20% |
| Dec 30, 2022 | 596.32M | 10.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |